Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A De Man

Showing results (41-50 of 222) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2018
Bacterascites: A study of clinical features, microbiological findings, and clinical significanceRosalie C Oey, Henk R van Buuren, David M de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can a decision-making model be justified in the management of hepatocellular adenoma?Susanna M van Aalten, Caroline D M Witjes, Robert A de Man, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
New insights in the management of Hepatocellular AdenomaAnne J Klompenhouwer, Robert A de Man, Marco Dioguardi Burgio, et al.
FEMS Immunology and Medical Microbiology|October 15, 2003
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy techniqueThjon J Tang, Harry L A Janssen, Johannes G Kusters, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[A patient with an alpha-foetoprotein producing tumour]Aafke H C van Roon, Pieter C J ter Borg, Pieter E Zondervan, et al.
Journal of Clinical Pathology|April 16, 2013
Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic liversCaroline D M Witjes, Fiebo J W ten Kate, Cornelis Verhoef, et al.
Journal of Hepatology|December 15, 2010
Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practiceSusanna M van Aalten, Joanne Verheij, Turkan Terkivatan, et al.
Antiviral Therapy|March 21, 2013
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavirRobert G Gish, Ting-Tsung Chang, Ching-Lung Lai, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 28, 2011
Safety and efficacy of radiofrequency ablation for hepatocellular adenomaMark G van Vledder, Sanne M van Aalten, Turkan Terkivatan, et al.
The American Journal of Gastroenterology|February 4, 2006
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotypeHajo J Flink, Monika van Zonneveld, Bettina E Hansen, et al.
Pageof 23

Showing results (41-50 of 222) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2018
Bacterascites: A study of clinical features, microbiological findings, and clinical significanceRosalie C Oey, Henk R van Buuren, David M de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can a decision-making model be justified in the management of hepatocellular adenoma?Susanna M van Aalten, Caroline D M Witjes, Robert A de Man, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
New insights in the management of Hepatocellular AdenomaAnne J Klompenhouwer, Robert A de Man, Marco Dioguardi Burgio, et al.
FEMS Immunology and Medical Microbiology|October 15, 2003
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy techniqueThjon J Tang, Harry L A Janssen, Johannes G Kusters, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[A patient with an alpha-foetoprotein producing tumour]Aafke H C van Roon, Pieter C J ter Borg, Pieter E Zondervan, et al.
Journal of Clinical Pathology|April 16, 2013
Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic liversCaroline D M Witjes, Fiebo J W ten Kate, Cornelis Verhoef, et al.
Journal of Hepatology|December 15, 2010
Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practiceSusanna M van Aalten, Joanne Verheij, Turkan Terkivatan, et al.
Antiviral Therapy|March 21, 2013
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavirRobert G Gish, Ting-Tsung Chang, Ching-Lung Lai, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 28, 2011
Safety and efficacy of radiofrequency ablation for hepatocellular adenomaMark G van Vledder, Sanne M van Aalten, Turkan Terkivatan, et al.
The American Journal of Gastroenterology|February 4, 2006
Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotypeHajo J Flink, Monika van Zonneveld, Bettina E Hansen, et al.
Pageof 23